Cleveland Clinic researchers create AI tool for Alzheimer’s target and drug discovery
The open-source artificial intelligence (AI) technology uses human genetic data to identify candidate drugs.
Cleveland Clinic study identifies blood pressure drug as potential treatment for Black patients with Alzheimer’s disease
Analyzing data from more than 5 million patients revealed telmisartan is associated with lower Alzheimer’s disease incidence in Black patients, providing clues for potential treatment and prevention.
Metformin identified as a potential atrial fibrillation treatment in collaborative research
How drugs and atrial fibrillation affect functions and genes in the body is the subject of a recent study into metformin and other candidate drugs.